Error Reduction Strategies for High-Alert Medications Kelly Besco, Pharm.D., FISMP, CPPS

Similar documents
Concentrated Insulin & Patient Management THE QUALITY CENTER PATIENT SAFETY ORGANIZATION FEBRUARY 27, 2018

Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies

DRUG ORDERING & DISPENSING:

Reducing the risk of patient harm: A focus on opioids

Comparative Storage and Utilization Analysis of Insulin Across Inpatient Hospital Settings

Sample Drug Incident Report Form

ISMP Targeted Medication Safety Best Practices. Christina Michalek, BS, RPh, FASHP

Disclosures. Learning Objectives 4/26/2017

CHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

Pharmacy Plan Guidance

Glossary. ISMP Medication Safety Self Assessment for High-Alert Medications

Conflict of Interest Declaration. High Risk Medications in the Hospital Pharmacy. According to. Learning Objectives. Medication Safety Organizations

ADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME

Objectives. Key Elements. ICAHN Targeted Focus Area: Drug Information and Drug Standardization and Distribution 3/24/2014

ISMP 2017 Updates Best Practices for Hospital Pharmacists

Patient Harm with Opioids: Can We Truly Reduce the Risk? Ali-Reza Shah-Mohammadi, PharmD, MS, FISMP

Medication Safety Presentation

Continuous Quality Improvement: Learning from Events

Technician Tutorial: Dispensing Insulin and Other Injectable Meds

Chapter 1: Fundamentals of Pharmacology Test Bank

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:

Allergy Status Identification And Documentation

High alert medicines

Procedure for the prescribing and administration of insulin

Script for audio: Pseudoephedrine and ephedrine. Audiovisual training for pharmacy support staff

Medical and Medication Errors CE Program. Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital

ADMINISTRATION OF INSULIN

These Aren t Your Average Rookies: A Primer on New and Emerging Insulins. Alissa R. Segal, Pharm.D, CDE, CDTC, FCCP

How do we fix the look-alike sound-alike puzzle? Specialist Pharmacy Service NCVO, London, Thursday 12 th July 2018

Sunderland Diabetes Network - Recommendations for safe prescribing of insulin.

U-500 Insulin: Not for Ordinary Use

Fundamentals of Pharmacology

ISMP Update on Top Medication Safety Issues from 2018

POPULATION TRACKER MIDS USER GUIDE

Guidance for Pharmacists on Safe Supply of Oral Methotrexate

Adverse Drug Events Steve Meisel, Pharm.D. Director of Patient Safety Fairview Health Services, Minneapolis, MN

Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit

Within the proportion the two outside numbers are referred to as the extremes. The two inside numbers are referred to as the means.

An Evaluation of the Barriers to Patient use of Glucometer Control Solutions: A Survey of Patients, Pharmacists, and Providers

Medication Management When Caring for Seniors at Home

Checklist/Action Plan for the Management of High-Alert Medications

High-Alert Medications: A Look at the Safe Use of Narcotics. Allen Vaida, BSc, PharmD Institute for Safe Medication Practices (ISMP)

ISMP Guidelines for Optimizing Safe Subcutaneous Insulin Use in Adults

Nova Scotia Drug Information System

Intrathecal. By the end of this chapter, you will be able to: Introduction. Chapter 20

2/9/2016. A Multi-Disciplinary Program to Decrease the Rate of Preventable Harm from Medication Events. Objectives:

CLINICAL DECISION SUPPORT FOR ME/ADE PREVENTION

Comprehensive Medication History Interview Form

Refilling a Prescription with No Refills Remaining

CHEMOTHERAPY DISPENSING

HIGH ALERT MEDICATIONS

Pyxis MedStation System. Guide for Managing Patient-Specific Medication

The Canadian National System for Incident Reporting in Radiation Treatment (NSIR-RT) Taxonomy March 11, 2015

Key Findings from the ISMP Canada Safety Bulletins Drugs: Oversight, Safety and Supply OHA Educational Event November 20, 2015 Toronto, ON

A Report of Participation in a Mentored Quality Improvement Activity for Insulin Pen Safety. St. Joseph s/candler Health System Savannah, Georgia

Guideline for the Rational Use of Controlled Drugs

AccuQuest Spotlight: Successful Fittings with Oasis. Fitting Range

POSITION STATEMENT. Safer design of vaccines packaging and labelling

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS

Point of Care (POC) Glucose Testing Revised on: December, 2018 Reference: Policy LAB 23-A; Point of Care Nova Stat Strip Glucose Meter

Knowledge Based Qualification for the NVQ3 (QCF) Diploma in Pharmacy Service Skills. Master Forms

This chapter shows how to use a formula method for dosage calculation to calculate the

Suicide Prevention: From a Pharmacist s Perspective. Daina L. Wells, Pharm.D., BCPS, BCPP VA PBM Academic Detailing Service

Improvement Science In Action. Improving Reliability

Information Sheet 10. Medication Hints and Tips (Updated August 2014)

FAQs for HCP segment New Instructions for Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System Non-Adjunctive Indication

FREQUENTLY ASKED QUESTIONS PHARMACISTS

Documenting Patient Immunization. New Brunswick 2018/19

SAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND. Sandra Brownstein, PharmD, CGP

Drug Incident Report Form

How to enter and update Immunizations using HF71

The Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association

Introduction. Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients)

Guidance on Bulk Prescribing for Care Home Residents

BOARD OF PHARMACY- REGULATORY UPDATE. Kimberly Grinston, J.D., Executive Director

QUALITY IMPROVEMENT TOOLS

Risk Management in Parenteral Nutrition. J. Boullata

HOW TO MANAGE AND ADMINISTER THE TRIAL TREATMENT

High Alert Medications in the long-term care setting. Carrie Allen PharmD, CGP, BCPS, CCHP

Documenting Patient Immunization. Ontario 2018/19

Dispensing Patient- Speci/ic Insulin. Paul Parchesky, RPh Pharmacy Manager Newport Hospital November 1, 2014

Rich Segal, R.Ph., Ph.D. Professor and Associate Dean University of Florida

ISMP guidelines that support intravenous drug delivery system safety

Nonparenteral medications

2015 Annual Convention

Rapid Response Report 2

Pharmaceutical risk management strategies for parenteral nutrition. J. Eastwood (UK)

Unit 204 Assist with the assembly of prescribed items

MyDispense OTC exercise Guide

Parenteral Nutrition

9/16/2013. No Conflict of Interest to Disclose

Compounding efficiency of Snap-N-Go vials compared to traditional sterile compounding techniques for vancomycin 1.5g and 2.0g

SECTION PRESCRIPTIONS

ProScript User Guide. Pharmacy Access Medicines Manager

Arkansas Pharmacy Law Update. John Clay Kirtley, Pharm.D. Assistant Director Arkansas State Board of Pharmacy

Introduction. Methods

Prevention of Transcription Errors with Pediatric TPN Orders Using a Web Interface

H1N1 Vaccine Administration Manual for Paramedics

Transcription:

Error Reduction Strategies for High-Alert Medications Kelly Besco, Pharm.D., FISMP, CPPS Medication Safety Officer OhioHealth Pharmacy Services

Conflict of Interest Disclosure Kelly Besco declares no conflicts of interest, real or apparent, and no financial interests in any company, product, or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria. 2

Objectives Describe troublesome process designs that often impact the safe use of high alert medications. Identify three key safety principles to use in medication error prevention. Differentiate between high leverage and low leverage error reduction strategies. 3

Principles of Safe Use of Medications Three principles to promote the safe use of medications 1) Reduce or eliminate the possibility of error 2) Make errors visible 3) Minimize the consequence of error 4

Reduce of Eliminate Possibility of Error Limit the number and variety of medications available for use. Examples: Isolate storage of medications to Pharmacy Ban on OTC sale of pseudoephedrine, which is used to make methamphetamine 5

Make Errors Visible Making errors visible can prevent patient harm from occurring. 6

Minimize Consequences of Error Practices can be changed to reduce effect of errors that occur. Closer monitoring can improve early detection of errors and prompt remedial action. 7

8 Error Reduction Strategies

Rank Order of Error-Reduction Strategies Strategy Fail-safes and Constraints Forcing Functions Automation and computerization ------------------------------------ Standardization Redundancies Reminders and checklists ------------------------------------- Rules and policies Education and information Suggestions to be more vigilant Car won t start if alcohol is detected on breath Reminder signs and checkpoints Rule/Law: It s illegal to drive over the allowable alcohol limit Power (Leverage) High Medium Low

Fail-safes Feature which, in the event of failure, responds in a way that will cause no harm or at least a minimum of harm. It is automatically activated in the event of failure.

Fail-safes Bubble detector: A safety device that detects air bubbles in the tubing, indicating that air was drawn into the line and a decreased delivery of the ingredient could result. 11

Constraints The state of being checked, restricted, or compelled to avoid or perform some action.

Forcing Functions Aspect of a design that prevents the user from taking an action without consciouslyconsidering information relevant to that action.

15

Standardize and Simplify Standardization reduces reliance on human memory and vigilance. Simplification of processes reduces load on memory, planning and problem solving. Standardization and simplification reduce variation and complexity. 16

Available Heparin Vial Concentrations 10 units/ml 100 units/ml 1 ml vial 10 ml vial 1,000 units/ml 1 ml vial 2 ml vial 10 ml vial 30 ml vial 5,000 units/ml 1 ml vial 10 ml vial 10,000 units/ml 1 ml vial 4 ml vial 5 ml vial 10 ml vial 20,000 units/ml 1 ml vial 5 ml vial

Order stated Cytoxan 4 g/m 2 days 1-4 (over 4 days) Given as 4 g/m 2 EACH DAY for four days

Benefits of Standardized Work Before implementing daily goals sheet: Less than 10% nurses and residents understood goals for care for the day After implementing daily goals sheet: Greater than 95% of nurses and residents understood the goals for care for the day ICU LOS decreased from a mean of 2.2 days to 1.1

21 Simplify

Differentiation Need to draw attention to differences between lookalike products. Strategies: 1) Remove one of the look-alike medications from use 2) Purchase one of the products from a different manufacturer 3) Use auxiliary warning labels 4) Barcode scanning 22

Reminders Examples: Warning labels Computerized warnings Visual aids 24

Redundancies A system of redundancies in which one person independently checks the work of another individual is essential to embed in processes involving high-risk medications and populations (e.g., pediatrics). 25

26 Case Study: Concentrated U-500 Insulin

Concentrated U-500 Insulin: Common Errors Dose Translation Incorrect doses translated when dose written as corresponding units on U-100 insulin syringe. Many good catches made by hospital with established Pharmacist verification protocol. Omissions Protocol was to use patient s own supply resulting in missed doses until medication brought in by patient s family. Patient Administration Events Patient administered own supply without physician order.

U-500 Insulin Safe Use Protocol Standardized order set Endocrinology consult Pharmacist double check Patient Interview Prescribing Transcribing Nursing education Patient specific doses Administration Storage/ Dispensing Separate storage Dispense in tuberculin syringe Product double check

Safe Use Protocol Prescribing

Safe Use Protocol Prescribing

Safe Use Protocol Prescribing

Safe Use Protocol Prescribing

Safe Use Protocol Prescribing Additional Ordering Parameters If an order is NOT completed on the order set, the reviewing Pharmacist contacts the prescriber. Pharmacists may complete the order as a telephone order if desired by the prescriber.

Safe Use Protocol Transcribing As an additional layer of safety, a process was approved for Pharmacists to interview the patient to verify their home dose of U-500 insulin. Akitwasdevelopedforuseduring the interview. The kit features a U-100 and Tuberculin syringe as well as an interview checklist. Orders are not transcribed by the Pharmacist until the interview is conducted.

Safe Use Protocol Transcribing During interview patient is asked which syringe they use to administer their insulin and demonstrate using the identified syringe, the dose they draw up into the syringe. A progress note is completed by the Pharmacist once the verification is completed. A standardized template was developed for the progress note. Pharmacist additionally updates electronic medication reconciliation list with home dose and notes the equivalent dose on a U-100 syringe.

Safe Use Protocol Transcribing Order Entry U-500 process checklist available to pharmacists Link in pop-up box in Pharmacy information system. Computer entry listing designed to reduce risk of incorrect selection. Default route to subcutaneous in computer system. Independent double check required to verify accuracy.

Safe Use Protocol Storage/Dispensing Storage U-500 vials are separated from other types of insulin in the Pharmacy. Vials are NOT stored in patient care areas. Stored in red high alert medication bins. Auxiliary labeled high potency

Safe Use Protocol Storage/Dispensing Dispensing Pharmacy dispenses individual doses to the units Tuberculin syringes Each dose labeled will high potency auxiliary sticker Each syringe requires a two Pharmacist double check prior to dispensing.

Safe Use Protocol Administration Since orders for U-500 insulin are rare, a Nursing Education sheet is sent with each dispensed syringe to remind Nursing staff of required safe practices.

Validate Effectiveness! Review was completed of patients that received U- 500 insulin over a 6 month period. 22 patients included in the review. Results of the review showed that overall, we are doing a GREAT job in following our safety protocol. Example: The Humulin Regular U-500 Insulin Order Set was completed in 100% of patients! There was 1 opportunity identified from the review related to completion of the Pharmacist Progress Note subsequent to the patient interview.

Opportunities Completion of Progress Note Pharmacist feedback was that the initial template provided for the progress note was too long and detailed; therefore, it was not being used 100% of the time. SOLUTION: A streamlined/shorter version of the progress note template was developed.

Process Improvement Revised Progress Note Template PHARMACOTHERAPY NOTE: INSULIN U-500 VERIFICATION Pharmacist has evaluated patient s home dose of insulin U-500 during an interview with the patient and/or caregiver and: Verified dose has been correctly ordered OR Physician has been contacted to correct order Please call with any questions. Pharmacist Name: Contact Number:

Rank Order of Error-Reduction Strategies Strategy Fail-safes and Constraints Forcing Functions Automation and computerization ------------------------------------ Standardization Redundancies Reminders and checklists ------------------------------------- Rules and policies Education and information Suggestions to be more vigilant Power (Leverage) High Medium Low

45 Risk Management Plan Design

Risk Control Error prevention strategies are not mutually exclusive. The fastest and easiest solution may not always be the best... may introduce new sources of error. People cannot be expected to compensate for weak systems Do not rely on education alone! 46

Prioritize Risk-Control Efforts High impact (for severity) Effect which has the greatest potential to cause harm Actionable Streamlines and simplifies, does not add complexity 47

48